ghk-cu downregulates pro-inflammatory genes Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy What is GHK-Cu | Peptides

Because of its short and variable half-life and its context-dependent activity profile, many published protocols time the dose close to the desired observation window, often in the evening

Invert slowly or swirl gently until everything dissolves

And as far as I'm concerned, there's no case reports or studies that would [160:09] Andrew Huberman suggest positive or negative CNS effects, central nervous system, excuse me, of BPC157 or other peptides that we've talked about that don't fall under the typical umbrella that people go to when they think about PPC 157

The useful question is whether the route is lawful, medically supervised, quality-controlled and supported by evidence for the exact use